Reduced Glutathione Sodium
Tier C — Watch / tradeReduced Glutathione Sodium
Targets：Not applicable
Indications (approved)：Acute respiratory distress syndrome, Liver disease, 酒精性肝炎, 酒精性肝硬化, 酒精性脂肪肝病, Sepsis, Anaemia
Regional status
Factories producing this API2
Factories registered as producing this API in our sourcing network (RFQ records + product master), sorted by RFQ activity; the snapshot carries no cost or customer data.
2 producing factories on file — sign in to view the named list (factory details are not shown to guests).
Sign in to view factories →Synthetic routes & intermediates2 routes
Routes are ordered originator first, then optimised / process (non-patent) routes; each lists steps, overall yield and the intermediate table (code / CAS / name) — ready for supplier sourcing and RFQ. Rendered by this site from structured data; no third-party route graphics used.
| Code | CAS No. | Intermediate |
|---|---|---|
| Reduced Glutathione Sodium-004 | 7048-04-6,52-89-1 | L-Cysteine hydrochloride |
| Reduced Glutathione Sodium-005 | 3054-01-1 | (2R)-2-Amino-3-(benzylsulfanyl)propanoic acid |
| Reduced Glutathione Sodium-006 | - | S-Benzyl-N-(tert-butoxycarbonyl)-L-cysteine |
| Reduced Glutathione Sodium-007 | 3257-18-9 | S-Benzyl-N-[(benzyloxy)carbonyl]-L-cysteine |
| Reduced Glutathione Sodium-008 | 623-33-6 | Ethyl 2-aminoacetate hydrochloride |
| Reduced Glutathione Sodium-009 | 51596-78-2 | Ethyl S-benzyl-N-(tert-butoxycarbonyl)-L-cysteinylglycinate |
| Reduced Glutathione Sodium-010 | 3695-79-2 | Ethyl S-benzyl-N-[(benzyloxy)carbonyl]-L-cysteinylglycinate |
| Reduced Glutathione Sodium-011 | 7669-84-3 | S-Benzyl-L-cysteinylglycine |
| Reduced Glutathione Sodium-012 | - | Benzyl [(3S)-2,6-dioxooxan-3-yl]carbamate |
| Reduced Glutathione Sodium-013 | 15401-16-8 | N-[(Benzyloxy)carbonyl]-L-gamma-glutamyl-S-benzyl-L-cysteinylglycine |
| Reduced Glutathione Sodium-014 | 6803-17-4 | L-gamma-Glutamyl-S-benzyl-L-cysteinylglycine |
| Reduced Glutathione Sodium-001 | 56-86-0 | L-alpha-Aminoglutaric acid |
| Reduced Glutathione Sodium-015 | 1155-62-0 | N-[(Benzyloxy)carbonyl]-L-glutamic acid |
Frequently asked questions
What are the approved indications of Reduced Glutathione Sodium?
Approved indications include: Acute respiratory distress syndrome, Liver disease, 酒精性肝炎, 酒精性肝硬化, 酒精性脂肪肝病, Sepsis, Anaemia.
When does the Reduced Glutathione Sodium patent expire?
No public expiry year is available for Reduced Glutathione Sodium yet; this page updates once verified.
How many synthesis routes are recorded for Reduced Glutathione Sodium?
2 synthesis routes are recorded; the shortest is 1 steps with 224mg(Reduced Glutathione Sodium (Free)) total yield. Intermediates in each route carry codes and CAS numbers.
Where can I buy Reduced Glutathione Sodium intermediates?
1 intermediate CAS of Reduced Glutathione Sodium are available through the Unibest supply network — see the route tables on this page and request a quote per CAS.
How do I get a quote for Reduced Glutathione Sodium intermediates?
Open the CAS profile of the target intermediate from this page, or submit an RFQ directly — the CAS enters the matching flow automatically and the supply network responds with quotes.
Source: cross-verified data (structured fields only) · 2026-09-29